半个多世纪以来,全世界用131I治疗Graves病(Graves dis-easr,GD)例数已超过150万。因该法简便、有效、安全,越来越多的临床医生将它作为治疗甲状腺功能亢进症(甲亢)的首选方法。在美国约69%的GD患者采用131I治疗。然而,继发甲状腺功能减退症(甲减)是131I治疗甲亢后最重要的并发 Over half a century, 131I has been used to treat Graves disease (Graves dis-easr, GD) in more than 1.5 million cases. Because the method is simple, effective and safe, more and more clinicians use it as the preferred method of treating hyperthyroidism (hyperthyroidism). Approximately 69% of GD patients in the United States are treated with 131I. However, secondary hypothyroidism (hypothyroidism) is the most important complication of 131I after hyperthyroidism